EUVIMEDEUVIMED entdecken
Crossref

Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women

Mamady Keita, Chen Xi, Abou Camara, Arbaba Balde, Kalil Cisse, Ibrahima Conde, Alhassane Toure, Malick Bah, Bangaly Traore, Hong Liu

Journal of Cancer Treatment and Research · 23.09.2025 · 13 (3) · 83-90

DOI: 10.11648/j.jctr.20251303.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Treatment and Research, online erschienen am 23.09.2025. Verfasst von Mamady Keita und 9 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: recurrence after treatment for uterine cervical cancer is not uncommon, and its management is a major challenge for the clinician. The aim of this study was to determine the maximum tolerated dose and dose-limiting toxicity of weekly chemotherapy combined with postoperative radiotherapy for uterine cervical cancer. Material and methods : Chinese women with localised uterine cervical cancer were recruited between 2017 and 2020. Pelvic radiotherapy (6 -10 MV X-rays, IMRT 40-45 Gy / 20 fractions, boost of 10-20 Gy/ 5-10fractions on parameters) was followed by brachytherapy ( 192 Ir, 10 - 20Gy/2-4fractions). Weekly chemotherapy was initiated with 20 mg/m 2 cisplatin and 10mg/m 2 paclitaxel. The 5 + 5 approach to escalate the dose for each 5 patients until the dose-limiting toxicity level was reached was used. Results : a total of 30 patients aged 32-78 years were included. Two out of 5 patients in the dose level 5 group developed grade 3 diarrhoea after 4 weeks. One patient in dose level 4 and 6 developed grade 4 leukopenia and neutropenia, respectively. There were no cases of delayed chemotherapy. With a median follow-up of 64.5 months, 3 patients died after recurrence of metastases. Conclusion : cisplatin - paclitaxel combined with postoperative radiotherapy has been shown to be highly effective and safe in Chinese women with localised uterine cervical cancer. The dose-limiting toxicities are 35 mg/m 2 cisplatin and 30 mg/m 2 paclitaxel per week for at least 6 cycles.

Zitieren

APA

Keita, M., Xi, C., Camara, A., Balde, A., Cisse, K., Conde, I., Toure, A., Bah, M., Traore, B., & Liu, H. (2025). Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women. Journal of Cancer Treatment and Research, 13(3), 83-90. https://doi.org/10.11648/j.jctr.20251303.16

Vancouver

Keita M, Xi C, Camara A, Balde A, Cisse K, Conde I, et al. Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women. Journal of Cancer Treatment and Research. 2025;13(3):83-90. doi:10.11648/j.jctr.20251303.16

BibTeX
@article{Keita2025,
  author = {Keita, Mamady and Xi, Chen and Camara, Abou and Balde, Arbaba and Cisse, Kalil and Conde, Ibrahima and Toure, Alhassane and Bah, Malick and Traore, Bangaly and Liu, Hong},
  title = {Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women},
  journal = {Journal of Cancer Treatment and Research},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {83--90},
  doi = {10.11648/j.jctr.20251303.16}
}
Kostenlos starten →